As of Apr 21
| -0.03 / -1.88%|
The 1 analysts offering 12-month price forecasts for MEI Pharma Inc have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a +59.24% increase from the last price of 1.57.
The current consensus among 2 polled investment analysts is to Hold stock in MEI Pharma Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.